| |
|
|
|
Tonix Pharmaceuticals Holding Corp.  
|
|
3.95 -0.04 (-0.01%) |
07-13 16:00 |
|
Open: |
4 |
Pre close: |
3.99 |
Target:
|
5.14 
|
|
High: |
4.17 |
Low: |
3.93 |
Resistance:
|
4.40
4.89
|
|
Volume: |
144,657 |
Market Cap: |
33M |
Support:
|
3.60
3.00
|
|
|
|
|
|
Technical Analysis |
|
Moving Averages |
MA(5):
|
3.91
|
MACD |
MACD(12,26):
|
0.01 |
|
MA(20): |
4.33  |
Signal(12,26,9): |
0.11 |
|
MA(100): |
3.48 |
Stochastic Oscillator |
%K(14,3):
|
28.42 |
|
MA(250): |
3.69 |
%D(3): |
25.75 |
|
Average Volume(K) |
3-Month: |
13353
|
52-Week |
High:
|
5.11 |
|
10-Days: |
15467 |
Low: |
2.70 |
|
RSI |
RSI(14):
|
46.40 |
Change(%): |
-9.0 |
|
Financials, Statistics and Valuation |
|
EPS |
-2.900 |
Return on Equity (ttm) |
-113.3 |
Shares Out. (M) |
8.46 |
|
EPS Est. Current Year |
-3.020 |
Return on Assets (ttm) |
-102.7 |
Shares Float (M) |
5.01 |
|
EPS Est. Next Year |
-2.470 |
PEG Ratio |
0.00 |
% Held by Insiders |
44.10 |
|
EPS Est. Next Quarter |
-0.740 |
Qtrly Rev. Growth |
0.0 |
% Held by Institutions |
25.40 |
|
Forward EPS |
-1.993 |
Gross Profit (p.s.) |
0.000 |
Shares Short (K) |
213 |
|
Book Value (p.s.) |
1.840 |
EBITDA (p.s.) |
-1.257 |
P/E |
-1.36 |
|
Sales Per Share |
0.000 |
Qtrly Earnings Growth |
0.00 |
P/BV |
2.15 |
|
Profit Margin |
0.00 |
Operating Cash Flow
(M) |
-19.13 |
P/S |
0.00 |
|
Operating Margin |
0.00 |
Levered Free Cash Flow
(M) |
-11.48 |
P/CF |
-1.75 |
|
|
|
|
|
|
